Tech Company Financing Transactions

Koronis Pharmaceuticals Funding Round

Koronis Pharmaceuticals, based in Seattle, secured $300 thousand in funding from Pacific Horizon Ventures.

Transaction Overview

Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Investors

Pacific Horizon Ventures (Jeffrey Miller)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
800 5th Ave. 4120
Seattle, WA 98104
USA
Email Address
Overview
Koronis Pharmaceuticals, Inc. is a privately held biotechnology companydeveloping anti-viral therapeutics based on Viral Decay Acceleration(TM).In addition to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has programs directed toward the development of therapeutics for hepatitis C and RSV.
Profile
Koronis Pharmaceuticals LinkedIn Company Profile
Social Media
Koronis Pharmaceuticals Company Twitter Account
Company News
Koronis Pharmaceuticals News
Facebook
Koronis Pharmaceuticals on Facebook
YouTube
Koronis Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Donald Elmer
  Donald Elmer LinkedIn Profile  Donald Elmer Twitter Account  Donald Elmer News  Donald Elmer on Facebook
Chief Executive Officer
Jean-Pierre Laurent
  Jean-Pierre Laurent LinkedIn Profile  Jean-Pierre Laurent Twitter Account  Jean-Pierre Laurent News  Jean-Pierre Laurent on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2009: Microposite venture capital transaction
Next: 3/31/2009: Adaptive Insights venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary